Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977

Journal of Viral Hepatitis

Volumn 4, Issue 6, 1997, Pages 379-381

  Grellier, L ^a   Brown, D ^a   Power, J ^b   Dusheiko, G ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Blood Transfusion Service Board   (Ireland)

Author keywords

Envelope glycoprotein; Hepatitis C antibodies; Hepatitis C virus; RIBA indeterminate

Indexed keywords

GLYCOPROTEIN E2, HEPATITIS C VIRUS; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS ENVELOPE PROTEIN;

ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; IRELAND; VIROLOGY;

COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IRELAND; VIRAL ENVELOPE PROTEINS;

EID: 0031298552     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00074.x     Document Type: Article

References (9)

1. Lesniewski R, Okasinski G, Carrick R et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viraemia. J Med Virol 1995; 45: 415-422.
2. Yuki N, Hayashi N, Kasahara A et al. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 1996; 23: 947-952.
3. Leon P, Lopez JA, Elola C, Domingo CJ, Echevarria JM. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. Vox Sang 1996; 70: 213-216.
4. Yokosuka O, Ito Y, Omata M. High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis. Gastroenterol Japonica 1993; 28 (suppl 5): 52-54.
5. Saracco G, Abate ML, Baldi M et al. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver 1994; 14: 65-70.
6. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995; 345: 1211-1213.
7. Tobler L, Busch M, Wilber J et al. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Transfusion 1994; 34: 130-134.
8. Tacke M, Kiyosawa K, Stark K et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-320.
9. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-1355.